As of January 2014, this journal has been sold to the Asset Publishing Group.
To access current articles please visit
http://www.impactjournals.com/Genes&Cancer/index.php
Genes & Cancer publishes original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology. Topics covered by the Journal are divided into four broad categories:
publishes original studies and reviews that are relevant to all aspects of cancer research, signal transduction, and developmental biology. Topics covered by the Journal are divided into four broad categories:
- Section One: the structure and function of cancer-associated genes as well as genes encoded by the DNA and RNA tumor viruses; Topics covered include the molecular oncology of human tumors, growth regulatory genes, microRNAs, cell cycle control, cancer stem cells, and cellular senescence. This section also covers the signal transduction pathways that are mediated by these genes.
- Section Two: devoted to the role played by these genes in normal development. This section covers studies that utilize gene knock-out and transgenic technologies to study the biological function of these genes in vivo.
- Section Three: devoted to genomics and epigenomics of cancer, which today is a burgeoning field. This also includes array-based and comparative genomic-based studies.
- Section Four: devoted to the discovery and mechanism of action of cancer therapeutics. This section encompasses small molecular experimental therapeutics as well as gene therapy approaches including siRNA- and shRNA-based therapies.
This journal is a member of the
Committee on Publication Ethics (COPE).
